Leary A - Search Results

1

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

Leary A, Evans A, Johnston SR, A'Hern R, Bliss JM, Sahoo R, Detre S, Haynes BP, Hills M, Harper-Wynne C, Bundred N, Coombes G, Smith I, Dowsett M. Leary A, et al. Among authors: a hern r. Clin Cancer Res. 2015 Jul 1;21(13):2932-40. doi: 10.1158/1078-0432.CCR-14-1428. Epub 2014 Nov 14. Clin Cancer Res. 2015. PMID: 25398453 Clinical Trial.

2

Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials?

Leary A, Smith I. Leary A, et al. Nat Clin Pract Oncol. 2006 Mar;3(3):126-7. doi: 10.1038/ncponc0447. Nat Clin Pract Oncol. 2006. PMID: 16520798 No abstract available.

3

Lapatinib: a novel EGFR/HER2 tyrosine kinase inhibitor for cancer.

Johnston SR, Leary A. Johnston SR, et al. Among authors: leary a. Drugs Today (Barc). 2006 Jul;42(7):441-53. doi: 10.1358/dot.2006.42.7.985637. Drugs Today (Barc). 2006. PMID: 16894399 Review.

4

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

Leary A, Dowsett M. Leary A, et al. Br J Cancer. 2006 Sep 18;95(6):661-6. doi: 10.1038/sj.bjc.6603316. Epub 2006 Aug 22. Br J Cancer. 2006. PMID: 16926831 Free PMC article. Review.

5

Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.

O'Brien ME, Borthwick A, Rigg A, Leary A, Assersohn L, Last K, Tan S, Milan S, Tait D, Smith IE. O'Brien ME, et al. Among authors: leary a. Br J Cancer. 2006 Dec 18;95(12):1632-6. doi: 10.1038/sj.bjc.6603498. Br J Cancer. 2006. PMID: 17160081 Free PMC article.

6

Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

Johnston SR, Martin LA, Leary A, Head J, Dowsett M. Johnston SR, et al. Among authors: leary a. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):180-6. doi: 10.1016/j.jsbmb.2007.05.019. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17624764 Review.

7

Small molecule signal transduction inhibitors for the treatment of solid tumors.

Leary A, Johnston SR. Leary A, et al. Cancer Invest. 2007 Aug;25(5):347-65. doi: 10.1080/07357900701259694. Cancer Invest. 2007. PMID: 17661211 Review.

8

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.

Leary AF, Sirohi B, Johnston SR. Leary AF, et al. Breast Cancer Res. 2007;9(5):112. doi: 10.1186/bcr1763. Breast Cancer Res. 2007. PMID: 17980056 Free PMC article.

9

Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?

Johnston SRD, Leary A, Martin LA, Smith IE, Dowsett M. Johnston SRD, et al. Among authors: leary a. Cancer. 2008 Feb 1;112(3 Suppl):710-717. doi: 10.1002/cncr.23190. Cancer. 2008. PMID: 18072235 Free article.

10

Survival from breast cancer in England and Wales up to 2001.

Leary A, Smith IE. Leary A, et al. Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S56-8. doi: 10.1038/sj.bjc.6604588. Br J Cancer. 2008. PMID: 18813261 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters